Back to Assenagon Asset Management S.A. Assenagon Asset Management S.A.

RYTMRYTM

Showing 8 of 21 quarters

Position history for Assenagon Asset Management S.A.Assenagon Asset Management S.A.'s holdings in RHYTHM PHARMACEUTICALS INC

Yes. Assenagon Asset Management holds 363,373 shares of RYTM (Rhythm Pharmaceuticals), worth $34.6M, as of its Q3 2026 13F filing. It increased the position by 176,882 shares (+94.9%) from Q2 2026. Assenagon Asset Management has held RYTM since Q2 2026, across 2 quarterly 13F filings.

Current Value

$34.6M

Current Shares

363,373

Total Value Change

+$33.5M

Total Shares Change

+343,321

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
363,373
+94.8%
$34.6M0.0%$95.22
46
2026-Q2
New
186,491
—
$20.7M0.0%$111.03
39
2025-Q4
Exited
0
-100.0%
$00.0%$107.04
0
2025-Q3
Decreased
224,128
-5.8%
$22.6M0.0%$100.99
0
2025-Q2
Increased
237,998
+972.5%
$15M0.0%$63.19
45
2025-Q1
New
22,192
—
$1.2M0.0%$52.97
35
2024-Q4
Exited
0
-100.0%
$00.0%$55.98
0
2024-Q3
Decreased
20,052
-91.3%
$1.1M0.0%$52.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used